Fructose: Substrate, Stimulus, or Both?
Sponsor: Touro University, California
A observational or N/A phase clinical study on Insulin Resistance and Insulin Sensitivity, this trial is ongoing. The trial is conducted by Touro University, California and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Apr 28, 2026 — Present [daily]
Active Not Recruiting
Status: Completed → Active Not Recruiting · Phase: NA → None
-
May 2025 — Apr 2026 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2024 — May 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2022 — Dec 2023 [monthly]
Recruiting NA
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2020 — Nov 2020 [monthly]
Recruiting NA
-
Dec 2019 — Apr 2020 [monthly]
Recruiting NA
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
Contact Information
- Touro University, California
For direct contact, visit the study record on ClinicalTrials.gov .